IP finance

"Where money issues meet IP rights". This weblog looks at financial issues for intellectual property rights: securitisation and collateral, IP valuation for acquisition and balance sheet purposes, tax and R&D breaks, film and product finance, calculating quantum of damages--anything that happens where IP meets money.

Showing posts with label Tufts Center for the Study of Drug Development. Show all posts
Showing posts with label Tufts Center for the Study of Drug Development. Show all posts
Monday, 2 May 2016

Costs of New Pharmaceutical Development Approaching US $3 Billion

›
The Tufts Center for the Study of Drug Development (“Tufts Center”) has recently published a study estimating the cost of new pharmaceutica...
›
Home
View web version
Powered by Blogger.